Protagonist Role of Opioidergic System on Post-Traumatic Stress Disorder and Associated Pain

키워드

참고문헌 (128)

1. Wang CH, "Post-traumatic stress disorder, depression, anxiety and quality of life in patients with traffic-related injuries", J Adv Nurs, 52, pp.22~30 (2005)
2. Shalev A, "Post-traumatic stress disorder", N Engl J Med, 376, pp.2459~2469 (2017)
3. Adhikari Baral I, "Post traumatic stress disorder and coping strategies among adult survivors of earthquake, Nepal", BMC Psychiatry, 19, pp.118~ (2019)
4. Spitzer RL, "Diagnostic and statistical manual of mental disorders", Paper presented at: American Psychiatric Association (1980)
5. Asmundson GJ, "PTSD and the experience of pain : research and clinical implications of shared vulnerability and mutual maintenance models", Can J Psychiatry, 47, pp.930~937 (2002)
6. Bisson JI, "Post-traumatic stress disorder", BMJ, 351, pp.h6161~ (2015)
7. Poundja J, "The co-occurrence of posttraumatic stress disorder symptoms and pain: Is depression a mediator?", J Trauma Stress, 19, pp.747~751 (2006)
8. Volpicelli J, "The role of uncontrollable trauma in the development of PTSD and alcohol addiction", Alcohol Res Health, 23, pp.256~262 (1999)
9. Holbrook TL, "Morphine use after combat injury in Iraq and post-traumatic stress disorder", N Engl J Med, 362, pp.110~117 (2010)
10. Castellano C, "The effects of morphine on memory consolidation in mice involve both D1 and D2 dopamine receptors", Behav Neural Biol, 61, pp.156~161 (1994)
11. Szczytkowski-Thomson JL, "Morphine prevents the development of stress-enhanced fear learning", Pharmacol Biochem Behav, 103, pp.672~677 (2013)
12. Vargas-Perez H, "BDNF signaling in the VTA links the drug-dependent state to drug withdrawal aversions", J Neurosci, 34, pp.7899~7909 (2014)
13. Duman EN, "Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain", J Pharmacol Sci, 94, pp.161~165 (2004)
14. Petrakis IL, "Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence", Neuropsychopharmacology, 37, pp.996~1004 (2012)
15. Dietis N, "Opioid receptor subtypes : fact or artifact", Br J Anaesth, 107, pp.8~18 (2011)
16. Sakoori K, "Central administration of nociceptin", orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice, 2004, pp.172, 129~136
17. Adams JM, "Increasing Naloxone Awareness and Use : The Role of Health Care Practitioners", JAMA, 319, pp.2073~2074 (2018)
18. Hyson RL, "Extent and control of shock affects naltrexone sensitivity of stress-induced analgesia and reactivity to morphine", Pharmacol Biochem Behav, 17, pp.1019~1025 (1982)
19. Hao JX, "Evidence that spinal endogenous opioidergic systems control the expression of chronic pain-related behaviors in spinally injured rats", Exp Brain Res, 118, pp.259~268 (1998)
20. Berna C, "Opioid-independent and opioid-mediated modes of pain modulation", J Neurosci, 38, pp.9047~9058 (2018)
21. Alisic E, "Rates of post-traumatic stress disorder in trauma-exposed children and adolescents : meta-analysis", Br J Psychiatry, 204, pp.335~340 (2014)
22. Defrin R, "Quantitative testing of pain perception in subjects with PTSDimplications for the mechanism of the coexistence between PTSD and chronic pain", Pain, 138, pp.450~459 (2008)
23. Roth RS, "The relation of post-traumatic stress symptoms to depression and pain in patients with accident-related chronic pain", J Pain, 9, pp.588~596 (2008)
24. Zou W, "Changes in the serum levels of inflammatory cytokines in antidepressant drug-naive patients with major depression", PLoS One, 13, pp.e0197267~ (2018)
25. Southwick SM, "Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder", Biol Psychiatry, 46, pp.1192~1204 (1999)
26. Wong ML, "Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features : relation to hypercortisolism and corticotropin-releasing hormone", Proc Natl Acad Sci U S A, 97, pp.325~330 (2000)
27. McEwen BS, "The neurobiology of stress : from serendipity to clinical relevance", Brain Res, 886, pp.172~189 (2000)
28. Lichtblau N, "Cytokines as biomarkers in depressive disorder : current standing and prospects", Int Rev Psychiatry, 25, pp.592~603 (2013)
29. Zhang Y, "Increased nociceptive sensitivity and nociceptin", orphanin FQ levels in a rat model of PTSD, 2012, pp.8, 76~
30. Curtis AL, "Pharmacological comparison of two corticotropin-releasing factor antagonists : in vivo and in vitro studies", J Pharmacol Exp Ther, 268, pp.359~365 (1994)
31. Curtis AL, "Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor : effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity", J Pharmacol Exp Ther, 281, pp.163~172 (1997)
32. Yehuda R, "Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event", Biol Psychiatry, 44, pp.1305~1313 (1998)
33. Cui H, "Effects of single-prolonged stress on neurons and their afferent inputs in the amygdala", Neuroscience, 152, pp.703~712 (2008)
34. Jovanovic T, "Neural mechanisms of impaired fear inhibition in posttraumatic stress disorder", Front Behav Neurosci, 5, pp.44~ (2011)
35. Siegmund A, "Toward an animal model of posttraumatic stress disorder", Ann N Y Acad Sci, 1071, pp.324~334 (2006)
36. Hendriksen H, "Environmental enrichment induces behavioral recovery and enhanced hippocampal cell proliferation in an antidepressant-resistant animal model for PTSD", PLoS one, 5, pp.e11943~ (2010)
37. Pitman RK, "Biological studies of post-traumatic stress disorder", Nat Rev Neurosci, 13, pp.769~787 (2012)
38. Roth MK, "Effects of chronic plus acute prolonged stress on measures of coping style, anxiety, and evoked HPA-axis reactivity", Neuropharmacology, 63, pp.1118~1126 (2012)
39. Volpicelli J, "The role of uncontrollable trauma in the development of PTSD and alcohol addiction", Alcohol Res Health, 23, pp.256~262 (1999)
40. Nuller YL, "Effect of naloxone therapy on depersonalization : a pilot study", J Psychopharmacol, 15, pp.93~95 (2001)
41. Abercrombie ED, "Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not non-stressful conditions", Brain Res, 441, pp.362~366 (1988)
42. Van’t Veer A, "Role of kappa-opioid receptors in stress and anxiety-related behavior", Psychopharmacology(Berl), 229, pp.435~452 (2013)
43. Lake EP, "Buprenorphine for the treatment of posttraumatic stress disorder", Am J Addict, 28, pp.86~91 (2019)
44. Henry MS, "Delta opioid receptor signaling promotes resilience to stress under the repeated social defeat paradigm in mice", Front Mol Neurosci, 11, pp.100~ (2018)
45. Foote SL, "Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal", Proc Natl Acad Sci U S A, 77, pp.3033~3037 (1980)
46. George SA, "Altered locus coeruleus-norepinephrine function following single prolonged stress", Euro J Neurosci, 37, pp.901~909 (2013)
47. Zomkowski AD, "Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test", Neurosci Lett, 381, pp.279~283 (2005)
48. Valentino RJ, "Locus ceruleus discharge characteristics of morphine-dependent rats : effects of naltrexone", Brain Res, 488, pp.126~134 (1989)
49. Butler RK, "Stress-induced analgesia", Prog Neurobiol, 88, pp.184~202 (2009)
50. Liberzon I, "Stress-restress : effects on ACTH and fast feedback", Psychoneuroendocrinology, 22, pp.443~453 (1997)
51. RaiseAbdullahi P, "Time-dependent protective effects of morphine against behavioral and morphological deficits in an animal model of posttraumatic stress disorder", Behav Brain Res, 364, pp.19~28 (2019)
52. Miczek KA, "Analgesia following defeat in an aggressive encounter : development of tolerance and changes in opioid receptors", Ann N Y Acad Sci, 467, pp.14~29 (1986)
53. Pitman RK, "Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study", Arch Gen Psychiatry, 47, pp.541~544 (1990)
54. Girardot MN, "Intermittent cold water stress-analgesia in rats : cross-tolerance to morphine", Pharmacol Biochem Behav, 20, pp.631~633 (1984)
55. Menendez L, "Opioid footshock-induced analgesia in mice acutely falls by stress prolongation", Physiol Behav, 53, pp.1115~1119 (1993)
56. Lewis JW, "Opioid and nonopioid mechanisms of stress analgesia", Science, 208, pp.623~625 (1980)
57. Hendrie CA, "The calls of murine predators activate endogenous analgesia mechanisms in laboratory mice", Physiol Behav, 49, pp.569~573 (1991)
58. Ribeiro SC, "Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors", Prog Neuropsychopharmacol Biol Psychiatry, 29, pp.1264~1280 (2005)
59. Chaturvedi S, "Postoperative pain and its management", Medknow Publications on behalf of the Indian Society of Critical Care Medicine, 11, pp.204~211 (2007)
60. Harvey AM, "Classification of chronic pain—descriptions of chronic pain syndromes and definitions of pain terms", Clin J Pain, 11, pp.163~ (1995)
61. Classification of chronic pain, "Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy", Pain Suppl, 3, pp.S1~S226 (1986)
62. West J, "Model Guidelines for the Use of Controlled Substances for the Treatment of Pain", A policy document of the Federation of State Medical Boards of the United States Inc, ~ (1998)
63. Harvey AM, "Classification of chronic pain-descriptions of chronic pain syndromes and definitions of pain terms", Clin J Pain, 11, pp.163~ (1995)
64. Wall P, "Inflammatory and neurogenic pain : new molecules, new mechanisms", Br J Anaesthes, 75, pp.123~124 (1995)
65. Carr DB, "Acute pain", Lancet, 353, pp.2051~2058 (1999)
66. Treede RD, "A classification of chronic pain for ICD-11", Pain, 156, pp.1003~1007 (2015)
67. Lam DK, "Neural mechanisms of temporomandibular joint and masticatory muscle pain : a possible role for peripheral glutamate receptor mechanisms", Pain Res Manag, 10, pp.145~152 (2005)
68. Gremillion HA, "Multidisciplinary diagnosis and management of orofacial pain", Gen Dent, 50, pp.178~189 (2002)
69. Goldberg DS, "Pain as a global public health priority", BMC Public Health, 11, pp.770~ (2011)
70. Yuan T, "Assessment of itch and pain in animal models and human subjects", Adv Exp Med Biol, 904, pp.1~22 (2016)
71. Matson DJ, "Inhibition of inactive states of tetrodotoxin-sensitive sodium channels reduces spontaneous firing of C-fiber nociceptors and produces analgesia in formalin and complete Freund’s adjuvant models of pain", PLoS one, 10, pp.e0138140~ (2015)
72. Gong N, "Pain assessment using the rat and mouse formalin tests", Bio-protocol, 4, pp.e1288~ (2014)
73. McCarson KE, "Models of inflammation : Carrageenan-or Complete Freund’s Adjuvant(CFA)-induced edema and hypersensitivity in the rat", Curr Protoc Pharmacol, 70, pp.5.4. 1~5.4. 9 (2015)
74. Bölcskei K, "Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice", Pain, 117, pp.368~376 (2005)
75. Watanabe M, "Expression and regulation of Cav3. 2 T-type calcium channels during inflammatory hyperalgesia in mouse dorsal root ganglion neurons", PLoS One, 10, pp.e0127572~ (2015)
76. Sprenger T, "Opioidergic activation in the medial pain system after heat pain", Pain, 122, pp.63~67 (2006)
77. Yu L, "The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund’s adjuvant", Mol Pain, 4, pp.61~ (2008)
78. Choi SI, "Emerging role of spinal cord TRPV1 in pain exacerbation", Neural Plast, 2016, pp.5954890~ (2016)
79. Tjølsen A, "The formalin test : an evaluation of the method", Pain, 51, pp.5~17 (1992)
80. Bodnar RJ, "Endogenous opiates and behavior : 2013", Peptides, 62, pp.67~136 (2014)
81. Holliday KL, "Do genetic predictors of pain sensitivity associate with persistent widespread pain?", Mol Pain, 5, pp.56~ (2009)
82. Aman Y, "Impaired chronic painlike behaviour and altered opioidergic system in the TASTPM mouse model of Alzheimer’s disease", Eur J Pain, 23, pp.91~106 (2019)
83. Hughes PA, "Opioidergic effects on enteric and sensory nerves in the lower GI tract : basic mechanisms and clinical implications", Am J Physiol Gastrointest Liver Physiol, 311, pp.G501~G513 (2016)
84. Willis WD Jr, "Central nervous system mechanisms for pain modulation", Appl Neurophysiol, 48, pp.153~165 (1985)
85. Julien N, "Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition", Pain, 114, pp.295~302 (2005)
86. Nafziger AN, "Opioid Therapy in Acute and Chronic Pain", J Clin Pharmacol, 58, pp.1111~1122 (2018)
87. Przewlocki R, "Opioids in chronic pain", Eur J Pharmacol, 429, pp.79~91 (2001)
88. Martin-Schild S, "Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord", Peptides, 18, pp.1641~1649 (1997)
89. Zadina JE, "A potent and selective endogenous agonist for the mu-opiate receptor", Nature, 386, pp.499~502 (1997)
90. Okada Y, "Endomorphins and related opioid peptides", Vitam Horm, 65, pp.257~279 (2002)
91. Pérez-Mañá C, "Drug interactions with new synthetic opioids", Front Pharmacol, 9, pp.1145~ (2018)
92. Leite-Almeida H, "Brain projections from the medullary dorsal reticular nucleus : an anterograde and retrograde tracing study in the rat", Neuroscience, 140, pp.577~595 (2006)
93. Ossipov MH, "Central modulation of pain", J Clin Investig, 120, pp.3779~3787 (2010)
94. Fields HL, "Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla", J Neurophysiol, 74, pp.1742~1759 (1995)
95. Moore RY, "Central catecholamine neuron systems : anatomy and physiology of the norepinephrine and epinephrine systems", Annu Rev Neurosci, 2, pp.113~168 (1979)
96. Kirby LG, "Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons", J Neurosci, 28, pp.12927~12937 (2008)
97. Basbaum AI, "Descending control of pain transmission : possible serotonergic-enkephalinergic interactions", Adv Exp Med Biol, 133, pp.177~189 (1981)
98. Loyd DR, "Morphine preferentially activates the periaqueductal gray-rostral ventromedial medullary pathway in the male rat : a potential mechanism for sex differences in antinociception", Neuroscience, 147, pp.456~468 (2007)
99. Kirby LG, "Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus", Neuropsychopharmacology, 22, pp.148~162 (2000)
100. Merrill RL, "Central mechanisms of orofacial pain", Dent Clin North Am, 51, pp.45~59 (2007)
101. Eippert F, "Activation of the opioidergic descending pain control system underlies placebo analgesia", Neuron, 63, pp.533~543 (2009)
102. Younger J, "Fibromyalgia symptoms are reduced by lowdose naltrexone : a pilot study", Pain Med, 10, pp.663~672 (2009)
103. Ueda M, "Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices", Neuropharmacology, 34, pp.303~308 (1995)
104. Scherrer G, "Dissociation of the opioid receptor mechanisms that control mechanical and heat pain", Cell, 137, pp.1148~1159 (2009)
105. Severino A, "Mu-opioid receptors in nociceptive afferents produce a sustained suppression of hyperalgesia in chronic pain", Pain, 159, pp.1607~1620 (2018)
106. Rutten K, "Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain", Eur J Pharmacol, 827, pp.41~48 (2018)
107. Porreca F, "Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury", Brain Res, 795, pp.197~203 (1998)
108. Thompson SJ, "Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat", Pain, 159, pp.1856~1866 (2018)
109. Machelska H, "Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord", J Pharmacol Exp Ther, 282, pp.977~984 (1997)
110. Neugebauer V, "Forebrain pain mechanisms", Brain Res Rev, 60, pp.226~242 (2009)
111. Seminowicz DA, "The dorsolateral prefrontal cortex in acute and chronic pain", J Pain, 18, pp.1027~1035 (2017)
112. Spivak B, "Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder", Biol Psychiatry, 42, pp.345~348 (1997)
113. Johnston IN, "A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine", J Neurosci, 24, pp.7353~7365 (2004)
114. Raghavendra V, "The role of spinal neuroimmune activation in morphine tolerance", hyperalgesia in neuropathic and sham-operated rats, 2002, pp.22, 9980~9989
115. Grabow TS, "Cervicomedullary intrathecal injection of morphine produces antinociception in the orofacial formalin test in the rat", Anesthesiology, 95, pp.1427~1434 (2001)
116. Capuano A, "Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception", Neuropharmacology, 58, pp.784~792 (2010)
117. Xu XJ, "Chronic pain-related behaviors in spinally injured rats : evidence for functional alterations of the endogenous cholecystokinin and opioid systems", Pain, 56, pp.271~277 (1994)
118. Roth RS, "The relation of post-traumatic stress symptoms to depression and pain in patients with accident-related chronic pain", J Pain, 9, pp.588~596 (2008)
119. Poundja J, "The co-occurrence of posttraumatic stress disorder symptoms and pain : is depression a mediator", J Trauma Stress, 19, pp.747~751 (2006)
120. Sharp TJ, "Chronic pain and posttraumatic stress disorder : mutual maintenance", Clin Psychol Rev, 21, pp.857~877 (2001)
121. Nazeri M, "Role of nitric oxide in altered nociception and memory following chronic stress", Physiol Behav, 129, pp.214~220 (2014)
122. Afari N, "PTSD, combat injury, and headache in Veterans Returning from Iraq", Afghanistan, 2009, pp.49, 1267~1276
123. Smitherman TA, "Trauma exposure versus posttraumatic stress disorder : relative associations with migraine", Headache, 53, pp.775~786 (2013)
124. Alkan A, "Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder(ORTHUS study) : a study of the palliative care working committee of the Turkish Oncology Group(TOG)", Support Care Cancer, 24, pp.3747~3755 (2016)
125. Coppens E, "Prevalence and impact of childhood adversities and post-traumatic stress disorder in women with fibromyalgia and chronic widespread pain", Eur J Pain, 21, pp.1582~1590 (2017)
126. Gameiro GH, "The effects of restraint stress on nociceptive responses induced by formalin injected in rat’s TMJ", Pharmacol Biochem Behav, 82, pp.338~344 (2005)
127. Parikh D, "Stress-induced analgesia and endogenous opioid peptides : the importance of stress duration", Eur J Pharmacol, 650, pp.563~567 (2011)
128. Zhang L, "Post-traumatic stress disorder risk and brainderived neurotrophic factor Val66Met", World J Psychiatry, 6, pp.1~6 (2016)

관련 논문AI추천